Literature DB >> 19433172

Relationship between serum citrulline levels and progression to parenteral nutrition independence in children with short bowel syndrome.

Shimae Fitzgibbons1, Y Avery Ching, Clarissa Valim, Jing Zhou, Julie Iglesias, Christopher Duggan, Tom Jaksic.   

Abstract

OBJECTIVE: Although bowel length is an important prognostic variable used in the management of children with short bowel syndrome (SBS), reliable measurements can be difficult to obtain. Plasma citrulline (CIT) levels have been proposed as surrogate markers for bowel length and function. We sought to evaluate the relationship between CIT and parenteral nutrition (PN) independence in children with SBS. STUDY
DESIGN: A retrospective chart review performed for all patients seen in a multidisciplinary pediatric intestinal rehabilitation clinic with a recorded CIT between January 2005 and December 2007 (n = 27).
RESULTS: Median age at time of CIT determination was 2.4 years. Diagnoses included necrotizing enterocolitis (26%), intestinal atresias (19%), and gastroschisis (22%). Citrulline levels correlated well with bowel length (R = 0.73; P < .0001) and was a strong predictor of PN independence (P Wilcoxon = 0.002; area under the receiver operating characteristic curve = 0.88; 95% confidence interval, 0.75-1.00). The optimal CIT cutoff point distinguishing patients who reached PN independence was 15 micromol/L (sensitivity = 89%; specificity = 78%).
CONCLUSION: Plasma CIT levels are strong predictors of PN independence in children with SBS and correlate well with a patient's recorded bowel length. A cutoff CIT level of 15 micromol/L may serve as a prognostic measure in counseling patients regarding the likelihood of future PN independence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19433172      PMCID: PMC3217826          DOI: 10.1016/j.jpedsurg.2009.01.034

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Serum citrulline levels correlate with enteral tolerance and bowel length in infants with short bowel syndrome.

Authors:  J Marc Rhoads; Emily Plunkett; Joseph Galanko; Steven Lichtman; Lesli Taylor; Angela Maynor; Timothy Weiner; Katherine Freeman; J Lindhe Guarisco; Guo Yao Wu
Journal:  J Pediatr       Date:  2005-04       Impact factor: 4.406

2.  Metabolism of citrulline in man.

Authors:  D Rabier; P Kamoun
Journal:  Amino Acids       Date:  1995-12       Impact factor: 3.520

3.  Influence of bacterial overgrowth and intestinal inflammation on duration of parenteral nutrition in children with short bowel syndrome.

Authors:  S S Kaufman; C A Loseke; J V Lupo; R J Young; N D Murray; L W Pinch; J A Vanderhoof
Journal:  J Pediatr       Date:  1997-09       Impact factor: 4.406

4.  Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors.

Authors:  S V Beath; P Davies; A Papadopoulou; A R Khan; R G Buick; J J Corkery; P Gornall; I W Booth
Journal:  J Pediatr Surg       Date:  1996-04       Impact factor: 2.545

5.  Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients.

Authors:  Gong Jianfeng; Zhu Weiming; Li Ning; Liu Fangnan; Tan Li; Luo Nan; Li Jieshou
Journal:  J Surg Res       Date:  2005-08       Impact factor: 2.192

6.  Predicting the duration of dependence on parenteral nutrition after neonatal intestinal resection.

Authors:  J M Sondheimer; M Cadnapaphornchai; M Sontag; G O Zerbe
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

7.  Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans.

Authors:  P Crenn; C Coudray-Lucas; F Thuillier; L Cynober; B Messing
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

8.  Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.

Authors:  Cinzia Papadia; Roy A Sherwood; Chrysostomos Kalantzis; Katharina Wallis; Umberto Volta; Erica Fiorini; Alastair Forbes
Journal:  Am J Gastroenterol       Date:  2007-04-24       Impact factor: 10.864

9.  Normal intestinal length in preterm infants.

Authors:  R J Touloukian; G J Smith
Journal:  J Pediatr Surg       Date:  1983-12       Impact factor: 2.545

10.  Small-intestine length in infants and children.

Authors:  J R Siebert
Journal:  Am J Dis Child       Date:  1980-06
  10 in total
  23 in total

1.  Plasma citrulline as marker of bowel adaptation in children with short bowel syndrome.

Authors:  Antonella Diamanti; Fabio Panetta; Paolo Gandullia; Francesco Morini; Cristian Noto; Giuliano Torre; Antonella Lezo; Bianca Goffredo; Antonella Daniele; Manuela Gambarara
Journal:  Langenbecks Arch Surg       Date:  2011-06-01       Impact factor: 3.445

2.  Plasma citrulline as surrogate marker of intestinal inflammation in pediatric and adolescent with Crohn's disease: preliminary report.

Authors:  Antonella Diamanti; Daniela Knafelz; Fabio Panetta; Fiammetta Bracci; Manuela Gambarara; Bronislava Papadatou; Antonella Daniele; Bianca M Goffredo; Simona Pezzi; Giuliano Torre
Journal:  Int J Colorectal Dis       Date:  2011-06-14       Impact factor: 2.571

3.  Efficacy of ethanol locks in reducing central venous catheter infections in pediatric patients with intestinal failure.

Authors:  Brian A Jones; Melissa A Hull; Denise S Richardson; David Zurakowski; Kathleen Gura; Shimae C Fitzgibbons; Debora Duro; Clifford W Lo; Christopher Duggan; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2010-06       Impact factor: 2.545

Review 4.  Short bowel syndrome in the NICU.

Authors:  Sachin C Amin; Cleo Pappas; Hari Iyengar; Akhil Maheshwari
Journal:  Clin Perinatol       Date:  2013-01-17       Impact factor: 3.430

Review 5.  Animal models of gastrointestinal and liver diseases. Animal models of infant short bowel syndrome: translational relevance and challenges.

Authors:  Per T Sangild; Denise M Ney; David L Sigalet; Andreas Vegge; Douglas Burrin
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-10-23       Impact factor: 4.052

6.  Serum citrulline as a biomarker of gastrointestinal function during hematopoietic cell transplantation in children.

Authors:  Kerri B Gosselin; Henry A Feldman; Andrew L Sonis; Lori J Bechard; Mark D Kellogg; Kathleen Gura; Robert Venick; Catherine M Gordon; Eva C Guinan; Christopher Duggan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-06       Impact factor: 2.839

7.  Use of serum citrulline concentrations from routine newborn screen as a biomarker for necrotizing enterocolitis.

Authors:  Sharmila Babu; Malavika Prasad; Malki Miller; Mark Morrissey; Alok Bhutada; Mary Rojas; Shantanu Rastogi
Journal:  Pediatr Surg Int       Date:  2019-03-09       Impact factor: 1.827

8.  Low serum citrulline concentration correlates with catheter-related bloodstream infections in children with intestinal failure.

Authors:  Melissa A Hull; Brian A Jones; David Zurakowski; Bram Raphael; Clifford Lo; Tom Jaksic; Christopher Duggan
Journal:  JPEN J Parenter Enteral Nutr       Date:  2011-03       Impact factor: 4.016

9.  Long-term intermittent glutamine supplementation repairs intestinal damage (structure and functional mass) with advanced age: assessment with plasma citrulline in a rodent model.

Authors:  A M Beaufrère; N Neveux; P Patureau Mirand; C Buffière; G Marceau; V Sapin; L Cynober; D Meydinal-Denis
Journal:  J Nutr Health Aging       Date:  2014-11       Impact factor: 4.075

10.  Predictors of a successful outcome for infants with short bowel syndrome: a 30-year single-institution experience.

Authors:  Tatsuru Kaji; Kazuhiko Nakame; Seiro Machigashira; Takafumi Kawano; Ryuta Masuya; Waka Yamada; Koji Yamada; Shun Onishi; Tomoe Moriguchi; Koshiro Sugita; Motoi Mukai; Satoshi Ieiri
Journal:  Surg Today       Date:  2017-04-22       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.